CNTB vs WELL · rev $64.0K vs P/E 100, rev $10.84B
Connect Biopharma Holdings Ltd (CNTB) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
CNTB currently screens at market cap $63.3M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the CNTB and WELL stock pages for the full models.
Not investment advice.